Coverage is product-, indication-, payer-, plan- and jurisdiction-specific. Use this checklist to obtain a current written determination for the exact proposed service.
Direct answer: coverage cannot be determined from the phrase “stem cell therapy”. It depends on the exact product or procedure, indication, payer, plan, provider network and preauthorisation rules. Obtain a written case-specific determination before relying on reimbursement.
| Payer | Covered? | Detail |
|---|---|---|
| US private insurance | Verify directly | Ask whether the exact product, indication, provider and associated services are covered, and request the decision in writing. |
| US Medicare | Verify directly | Use current Medicare coverage records and ask the provider to confirm the exact billing codes before treatment. |
| US Medicaid | Verify by state and plan | Coverage and prior-authorisation rules vary; obtain a written plan-specific determination. |
| UK NHS | Verify the exact pathway | Check current NHS guidance and whether the proposed care is an established commissioned service or research. |
| EU statutory insurers | Verify by country and insurer | Coverage depends on the exact authorised indication, national policy, referral route and individual eligibility. |
| Registered clinical trials | Check the study record | A registry listing does not establish that treatment or travel is free. Ask the study contact which costs the sponsor covers. |
General guidance, not a benefits determination — always confirm with your own insurer for your specific plan and condition.
Coverage is product-, indication-, payer- and plan-specific. Ask the payer to evaluate the exact procedure and billing codes in writing; do not infer coverage from the broad label 'stem cell therapy'.
Medicare coverage depends on the exact covered service, indication, setting and applicable policy. Check current Medicare guidance and obtain a case-specific determination before treatment.
Common reasons include investigational status, an excluded service, insufficient evidence for the indication, an out-of-network provider or missing preauthorisation. Only the payer can determine the actual reason for a specific plan.
Three planning steps: (1) check whether a registered ClinicalTrials.gov study is recruiting and confirm its terms; (2) compare sourced indicative prices without assuming equivalent care; (3) verify provider credentials, protocol scope and the all-in travel figure.
| Condition | Coverage details |
|---|---|
| Autism Spectrum Disorder | Confirm product-specific coverage directly with the payer |
| Diabetes (Type 1 & 2) | Confirm product-specific coverage directly with the payer |
| Multiple Sclerosis | Confirm product-specific coverage directly with the payer |
| Parkinson's Disease | Confirm product-specific coverage directly with the payer |
| Alzheimer's Disease | Confirm product-specific coverage directly with the payer |
| Cerebral Palsy | Confirm product-specific coverage directly with the payer |
| Spinal Muscular Atrophy | Confirm product-specific coverage directly with the payer |
| Muscular Dystrophy | Confirm product-specific coverage directly with the payer |
| Rheumatoid Arthritis | Confirm product-specific coverage directly with the payer |
| Liver Cirrhosis | Confirm product-specific coverage directly with the payer |
| Anemia | Confirm product-specific coverage directly with the payer |
| Arterial Hypertension | Confirm product-specific coverage directly with the payer |
| Erectile Dysfunction | Confirm product-specific coverage directly with the payer |
| Male Infertility | Confirm product-specific coverage directly with the payer |
| Primary Immunodeficiency | Confirm product-specific coverage directly with the payer |
| Aesthetic & Anti-Ageing | Confirm product-specific coverage directly with the payer |
| Intellectual Disability | Confirm product-specific coverage directly with the payer |
| Knee Osteoarthritis | Confirm product-specific coverage directly with the payer |
| Back Pain & Disc Degeneration | Confirm product-specific coverage directly with the payer |
| Peripheral Neuropathy | Confirm product-specific coverage directly with the payer |
| Stroke Recovery | Confirm product-specific coverage directly with the payer |
| COPD & Lung Disease | Confirm product-specific coverage directly with the payer |
| Crohn's & IBD | Confirm product-specific coverage directly with the payer |
| Lupus (SLE) | Confirm product-specific coverage directly with the payer |
| Chronic Kidney Disease | Confirm product-specific coverage directly with the payer |
| Hair Loss & Restoration | Confirm product-specific coverage directly with the payer |
| Long COVID | Confirm product-specific coverage directly with the payer |
| Spinal Cord Injury | Confirm product-specific coverage directly with the payer |
| Heart Failure & Cardiac Repair | Confirm product-specific coverage directly with the payer |
| ALS (Motor Neurone Disease) | Confirm product-specific coverage directly with the payer |
| Psoriasis | Confirm product-specific coverage directly with the payer |
| Osteoporosis & Bone Health | Confirm product-specific coverage directly with the payer |
| Tendon & Sports Injuries | Confirm product-specific coverage directly with the payer |
| Chronic Wounds & Ulcers | Confirm product-specific coverage directly with the payer |
| Macular Degeneration & Vision | Confirm product-specific coverage directly with the payer |
| Fibromyalgia & Chronic Fatigue | Confirm product-specific coverage directly with the payer |
| Hip Osteoarthritis | Confirm product-specific coverage directly with the payer |
| Scleroderma (Systemic Sclerosis) | Confirm product-specific coverage directly with the payer |
| Premature Ovarian Insufficiency | Confirm product-specific coverage directly with the payer |
| Menopause & Hormonal Health | Confirm product-specific coverage directly with the payer |
| Complex Regional Pain Syndrome | Confirm product-specific coverage directly with the payer |
| Ulcerative Colitis | Confirm product-specific coverage directly with the payer |
StemCellAtlas is a source-first research and cost-planning guide. It separates registry and regulator evidence from heterogeneous commercial observations.
Get an honest assessment